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Potential genetic determinants of dengue virulence were studied by sequencing the entire genomes of eight dengue 2 virus
strains isolated from patients exhibiting different disease severities during an epidemic season in northeastern Thailand in
1993. The isolates came from one dengue shock syndrome (ThNH-7/93), three dengue hemorrhagic fever, and four dengue
fever patients. Phylogenetic analysis showed that the isolates belonged to the Southeast Asian genotype. The 39 noncoding
regions showed distinctive secondary structures, with one specific structure for the isolate ThNH-7/93. Analysis of the
predicted polyprotein showed several amino acid (aa) changes scattered mostly in the nonstructural region. Of 30 positions
with aa changes, 7 were unique to the isolate ThNH-7/93 and 3 of those led to radical alterations in aa character. Several
aa changes coincided with previous studies relating genome sequence and virulence. Minimal changes in computer-
predicted protein secondary structures were observed. Infective particles in the inoculum for all isolates were approximately
equal as measured by focus formation on BHK-21 cells, but this did not correlate with the number of plaques formed on
LLC-MK2 cells. Isolates from patients that experienced secondary infections were shown to have significantly larger plaques
than the isolates from primary infection patients. © 1998 Academic Press
INTRODUCTION
Dengue fever and dengue hemorrhagic fever/dengue
shock syndrome are major health problems in the tropics
and in subtropical regions. The increasing number of
patients, the expansion of epidemic areas, and the in-
crease in incidence of severe clinical manifestations
have led to extensive research on its causative agent,
the dengue virus, the most important arthropod-borne
virus in terms of morbidity and mortality (Monath, 1986;
Monath and Heinz, 1996).
The dengue viruses (DEN-1 to -4) belong to the genus
Flavivirus of the family Flaviviridae which are composed of
positive-sense, single-stranded RNA viruses. The viral ge-
nome is approximately 10,700 bases in length and a single
polyprotein is produced from one long open reading frame
from which individual proteins are cleaved by cellular and
viral proteases. The gene order of the dengue polyprotein is
59-C-prM(M)-E-NS1-NS2a-NS2b-NS3-NS4a-NS4b-NS5-39
and is the same for all sequenced members of the Flavi-
viridae family (Rice, 1996). All four serotypes have been
sequenced by previous investigators (Zhao et al., 1986;
Deubel et al., 1988; Hahn et al., 1988; Irie et al., 1989;
Osatomi and Sumiyoshi, 1990; Fu et al., 1992).
A dengue infection can be manifested in a range of
symptoms from mild dengue fever (DF) to severe and often
fatal dengue hemorrhagic fever/dengue shock syndrome
(DHF/DSS), all of which may be observed during a dengue
outbreak. The mechanism by which the dengue virus can
exhibit benign or severe symptoms has not been fully elu-
cidated, though several theories have been proposed. The
antibody-dependent enhancement theory postulates that
circulating antibodies from a primary infection bind to het-
erologous infecting virus enhancing infection of mononu-
clear cells (Halstead, 1988; Littaua et al., 1990). Further
studies have shown that the host immune system media-
tors, such as cytokines and complement, may play a direct
role in the occurrence of plasma leakage, the defining
feature of DHF (Malasit, 1987; Kurane and Ennis, 1992,
1994; Chaturvedi et al., 1994). The occurrence of primary
infection cases which develop into DHF/DSS (Barnes and
Rosen, 1974; Scott et al., 1976) is indicative of the role of
host-related factors and variations in the virus population
that can give rise to more virulent strains (Rosen, 1977).
Dengue outbreaks in the Kingdom of Tonga in the period
1974–1975 is one of the earlier studies which introduced the
possibility that virulent forms of the virus are circulating and
may cause DHF/DSS (Gubler et al., 1978). Both hypotheses
are supported by research data and both are probably
involved in the occurrence of severe manifestations during
The nucleotide sequence reported in this study have been submitted
to the GenBank Data Library under Accession Nos. AF022434 (ThNH-
7/93), AF022435 (ThNH-28/93), AF022436 (ThNH-52/93), AF022437
(ThNH-p11/93), AF022438 (ThNH-p12/93), AF022439 (ThNH-p14/93),
AF022440 (ThNH-p16/93), and AF022441 (ThNH-p36/93).
1 To whom reprint requests should be addressed at present address:
Division of Tropical Medicine, Medical Research Institute, Kanazawa
Medical University, Daigaku 1-1, Uchinada, Kahoku Gun, Ishikawa 920-
0265, Japan. E-mail: maloy@ep.tm.nagasaki-u.ac.jp.
VIROLOGY 244, 458–466 (1998)
ARTICLE NO. VY989093
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
458
dengue epidemics (Gubler and Trent, 1994; Rico-Hesse
et al., 1997).
Molecular markers of virulence and attenuation have
been shown to occur, specifically for flaviviruses (Evans
et al., 1985; Hahn et al., 1988; Holzmann et al., 1990;
Hasegawa et al., 1992; Jennings et al., 1993; Sumiyoshi et
al., 1995; Ni and Barrett, 1996). The increase of sequence
data and the construction of recombinant full-length den-
gue viral genomes has seen an increase in the studies
relating neurovirulence, growth restriction, and immuno-
genicity (Lai et al., 1991; Blok et al., 1992; Kawano et al.,
1993; Cahour et al., 1995; Kinney et al., 1997).
In this study we compare eight dengue type 2 viruses
isolated from patients exhibiting different disease sever-
ities by determining the genomic nucleotide sequences,
predicted amino acid sequences, and several biological
in vitro properties of these isolates. These results would
help to identify regions of the dengue genome which
contribute to virulence and also to increase understand-
ing of the pathogenesis of a dengue virus infection and
eventually aid in its treatment and prevention.
RESULTS
Nucleic acid sequence analysis of all isolates
We have determined the sequence of eight dengue vi-
ruses isolated from patients exhibiting different disease
severities (Table 1). Comparative differences in nucleotide
and amino acid numbers between all isolates, the dengue
2 New Guinea C prototype, and the sequenced DEN-2
16681 DSS isolate are shown in Table 2. Results show high
nucleic acid sequence homology (95.33–95.43%) of the iso-
lates compared with the prototype strain. Intraisolate ho-
mologies ranging from 98.17 to 99.97% were determined
from the sequence data. The primary sequences of the 59
noncoding regions of all isolates were the same and iden-
tical to that of the prototype NGC strain. Percentage differ-
ence of the 39 noncoding regions’ nucleotide sequences
TABLE 1
Medical Data and in Vitro Experimental Results of Eight Dengue Type 2 Isolates from Thailand
Medical data
In vitro data
Isolate
name Diagnosis
Serological
response Sex Age
Relevant dates
FFU/ml
(BHK-21)
PFU/ml
(LLC-MK2)
Average plaque size
(mm) (LLC-MK2)Onset Sampling
ThNH7/93 DSS Secondary F 12 06–17 06–18 1.25 3 106 1.75 3 104 1.67
ThNH28/93 DHF(2) Secondary M 10 06–19 06–21 4.4 3 106 7.5 3 104 2.75
ThNH52/93 DHF(1) Secondary M 7 06–22 06–23 2.65 3 106 1.5 3 106 2.7
ThNHp11/93 DF Primary M 14 I.U.b 06–30 4.5 3 106 1.75 3 105 0.82
ThNHp12/93 DF Secondary F 11 I.U. 06–30 6.1 3 106 2.0 3 105 2.65
ThNHp14/93 DF/DHF(1)a Secondary M 11 06–26 06–29 7.9 3 106 6 3 105 2.13
ThNHp16/93 DF Primary F 12 I.U. 06–30 2.5 3 106 '104 ,0.5
ThNHp36/93 DF Primary F 9 I.U. 06–30 3.95 3 106 '104 ,0.5
a Refer to text for details of ThNHp14–93.
b Information unavailable.
TABLE 2
Difference in Number of Genomic Nucleotides and Amino Acids among All Eight Dengue 2 Thai Isolates Including the Dengue 2 Prototype
Strain New Guinea C (DEN2-NGC) and One Sequenced DSS Strain, DEN-2 16681
DEN2-
NGC
DEN2-
16681
ThNH-
7/93
ThNH-
28/93
ThNH-
52/93
ThNH-
p11/93
ThNH-
p12/93
ThNH-
p14/93
ThNH-
p16/93
ThNH-
p36/93
DEN2-NGC — 326 494 492 496 498 497 500 494 494
DEN2-16681 44 — 578 333 337 350 349 352 336 339
ThNH-7/93 59 41 — 151 155 194 192 195 154 156
ThNH-28/93 56 36 14 — 4 186 184 187 4 7
ThNH-52/93 58 38 16 2 — 190 188 191 8 7
ThNH-p11/93 55 36 19 19 21 — 9 8 189 192
ThNH-p12/93 53 34 17 17 19 2 — 9 187 189
ThNH-p14/93 54 35 18 18 20 2 1 — 190 192
ThNH-p16/93 54 37 15 1 3 20 18 19 — 11
ThNH-p36/93 57 37 15 1 1 20 18 19 2 —
Note. Data above the diagonal represent nucleotide differences and those below the diagonal represent amino acid differences for all isolates.
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ranged from 1.33 to 1.55%. The amino acid sequence differ-
ences are shown in Table 3. As with the nucleotide data,
high amino acid sequence homology (98.25–98.45%) be-
tween all isolates and the prototype NGC strain was ob-
served. Intraisolate homology ranged from 99.40 to 99.95%.
All cysteine residues were conserved among all isolates
and also as compared to three reference dengue 2 se-
quences (NGC, S1, Jamaica). Homology analysis of all iso-
lates as compared to the DEN-2 16681 sequence (Kinney et
al., 1997) taken from a DSS patient showed that ThNH-
p12/93 had the highest homology (98.99%, 34 amino acid
differences) and ThNH-7/93 had the lowest (98.79, 41
amino acid differences). The C and M proteins were per-
fectly conserved among all the isolates. The prM region
was shown to have two amino acid changes, at positions
16 (I7R) and 81 (T7A). The latter difference could bring
about a secondary structural change at the C-terminus of
this protein. A single amino acid substitution (R7K) was
found in the E-protein which did not alter the character of
the residue significantly. A total of 27 amino acid substitu-
tions were scattered along the nonstructural region of the
viral polyprotein among all eight isolates and the following
amino acid substitutions were noted since they conferred a
radical change in character of the residue at the given
positions: 278 (G7D) of NS1; 63 (A7T) and 138 (D7N) of
NS2a; 12 (I7M) and 118 (T7A) of NS3; 165 (L7F) of NS4a;
2 (T7A), 196 (T7A), 337 (T7M), and 793 (T7I) of NS5.
Hydrophobicity profiles of all isolates were similar, average
hydrophobicities being mostly equal for all regions of the
polyprotein. No significant differences among all isolates
were seen from the computed secondary structures of the
different proteins of the virus. In the NS2a protein, the I7M,
D7N, A7V, and L7I changes at positions 136, 138, 167,
and 181, respectively, with emphasis on the residue at
position 167, may have brought about small secondary
structure changes between the isolates (data not shown).
All confirmed and potential N-glycosylation sites, as well
as the RGD cell membrane binding sequence found at
position 538 of the NS3 protein, were perfectly conserved
among all the isolates as well as the NGC prototype strain.
Predicted secondary structures for the 39 noncoding
regions
Structural predictions by computer analysis of the 39 non-
coding regions yielded conformations which divided the iso-
TABLE 3
Summary of Amino Acid Sequence Differences among All Eight Dengue 2 Isolates
Amino acid
residue No.a
ThNH-
7/93
ThNH-
28/93
ThNH-
52/93
ThNH-
p11/93
ThNH-
p12/93
ThNH-
p14/93
ThNH-
p16/93
ThNH-
p36/93
prM 16 I I I R R R I I
81 T T T A A A T T
E 334 K R R K K K R R
NS1 227 R K K K K K K K
278 G D D D D D D D
281 D D D E E E D D
NS2a 41 V V V M M M V V
63 A T T A A A T T
94 K R R R R R R R
136 I I I M M M I I
138 D N N N N N N N
167 A V V V V V V V
181 L I I L L L I I
215 N N N S S S N N
NS3 12 I M M M M M M M
118 T T T A A A T T
201 R R K R R R R K
394 A V V V V V V V
NS4a 3 T A A T T T A A
165 L F F L L K F F
169 A A A V V V A A
NS4b 101 S S T S S S S S
NS5 2 T T T A T T T T
196 T A A T T T A A
337 T T T M M M T T
412 I I I V V V I I
637 V A A V V V A A
701 N N N N N S N N
723 V V V V V V L V
793 T T T I T T T T
a The amino acid residue number corresponds to the position in the respective proteins.
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lates into several groups, as shown in Fig. 1. No specific
correlation was seen between the structures and the clinical
severity of the patient, though a specific structure was pre-
dicted for ThNH-7/93 which was isolated from a DSS case.
The 39 noncoding region of the sequenced DSS isolate DEN-2
16681 (Kinney et al., 1997) was also analyzed and showed a
structure similar to that predicted for ThNH-28, 52/93. Analysis
of 39 noncoding regions of published dengue sequences
show similar stem-loop structures with varying degrees of
irregularities along the stem.
Phylogenetic analysis of all isolates
Neighbor-joining analysis of the genomic sequences
shows all isolates clustering together and closely
FIG. 1. Comparison of predicted secondary structures of nucleotides 10347–10463 (10464) from eight dengue type 2 isolates from Thailand and the
DEN-2 16681 strain isolated from a DSS patient. DG is the free energy of formation of each structure.
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grouped to one Thai isolate from 1964 and to the New
Guinea C prototype strain, all of which are subgrouped
into genotype II as determined by Thant et al. (1995) or
the Southeast Asian genotype according to Rico-Hesse’s
(1990) nomenclature. The dendrogram (not shown) gen-
erated from the E/NS1 gene junction sequences showed
a distinctive grouping of ThNH-p11, p12, and p14/93,
while the rest of the isolates grouped with the Thai
isolate from 1964.
Focus formation of dengue-2-infected BHK-21 cells
Infectivity assays were performed to determine the
phenotypic characteristics of the virus, as well as in vitro
characteristics that could be related to variations in their
phenotypic expression in the human host. The infectivity
of the isolates was measured in focus-forming units
(FFU) and the value for each isolate is shown in Table 1.
The infectivity for all isolates is relatively constant in the
order of 106 FFU/ml.
Phenotype characterization by plaque formation
on LLC-MK2 cells
Figure 2 illustrates the plaque differences among all
eight isolates. Infectivity as measured in plaque-forming
units (PFU/ml) is shown in Table 1, along with average
plaque size for each isolate. Infectivity by plaque forma-
tion, in contrast to the focus formation assay, shows
variable results for each of the isolates, ranging from 104
to 106 PFU. The results also show that ThNH-7/, 28/, 52/,
p12/, and p14/93 have significantly larger plaques than
the rest of the isolates. Inoculum concentration for
ThNH-p16 and p36/93 was higher than that for the other
isolates, as shown in Fig 2, because the plaques from
these two isolates were diffuse in morphology and ap-
peared, under the microscope, to be the result of the
overlapping of several small plaques. The next higher
(twofold) dilution of inoculum did not give rise to any
visible plaques. Viruses freshly isolated from human se-
rum samples have been observed to be difficult to han-
dle in vitro. Our samples were no exception; thus, we had
to perform extensive optimization experiments to get the
best possible plaque morphology while maintaining
proper controls. Previous workers usually passaged iso-
lates several times to get higher titers (Morens et al.,
1991) and better in vitro viral phenotypes (Yuill et al.,
1968). The adaptation to growth in LLC-MK2 cells may
induce changes in the genomic nucleotide sequence;
thus, we minimized passages from serum samples.
DISCUSSION
Recent studies concerning genetic determinants of
virulence in flaviviruses (Barrett et al., 1990; Holzmann et
al., 1990; Lobigs et al., 1990; Cecilia and Gould, 1991;
Jennings et al., 1994; Sumiyoshi et al., 1995; Ni and
Barrett, 1996) and specifically in dengue (Fong et al.,
1990; Blok et al., 1991, 1992; Kawano et al., 1993; Pletnev
et al., 1993; Men et al., 1996; Kinney et al., 1997) have
determined molecular markers of attenuation. This report
takes a direct approach by investigating isolates taken
from patients exhibiting different disease severities from
a single dengue outbreak.
Sequence homology analysis shows that all isolates
are closely related and may have evolved from a 1964
Thai isolate strain.
Putative structures in the 39 noncoding region specific
for each of the viruses isolated from DF, DHF, and DSS
cases were determined previously (Mangada and Iga-
rashi, 1997). New data from four DF isolates showed
structures similar to those of the DHF isolates with only
ThNH-p14/93, having a structure similar to that of ThNH-
p11/93. The unique secondary structure of ThNH-7/93
includes an irregularity at the loop of the long stem-loop
structure, though another sequenced DSS strain, DEN-2
16681, gives a structure similar to that of ThNH-28 and
52/93. This region of the viral genome plays a role in
replication and growth of the virus (Hahn et al., 1987;
Men et al., 1996).
We identified 30 residues which exhibited differences
among the isolates; 7 were unique to ThNH-7/93 and are
found in the nonstructural protein regions. Previous pub-
lications detected most determinants of attenuation in
the structural proteins. The amino acid change from
G7D at residue 278 of the NS1 protein, the V7A change
in position 394 of NS3, and the L7I amino acid change
at position 181 of the NS2a protein are analogous to
results in previous publications (Fong et al., 1990; Blok et
al., 1992; Kinney et al., 1997). The isolate from the DSS
patient (ThNH-7/39) shows the greatest divergence
across the whole viral genome when compared to the
other isolates. NS1 gene sequences of four viruses iso-
lated from an epidemic in Thailand in 1980 (Blok et al.,
1991) were also compared and no correlation could be
identified between disease severity and nucleotide and
amino acid sequences.
Host and viral factors have to account for severe
manifestations of dengue which occur in primary infec-
tion cases (Rosen, 1977; Gubler et al., 1978; Kurane and
Ennis, 1994), though these host and viral factors would
also be expected to play a role in secondary infection
FIG. 2. Plaque morphology of eight dengue type 2 isolates from Thailand on LLC-MK2 cell monolayers. Cells were stained with crystal violet 11
days after virus inoculation. Concentration of virus inoculum in this figure for ThNH-p16 and p36/93 are higher than for the rest of the isolates. (A)
ThNH-7/93; (B) ThNH-28/93; (C) ThNH-52/93; (D) ThNH-p11/93; (E) ThNH-p12/93; (F) ThNH-p14/93; (G) ThNH-p16/93; (H) ThNH-p36/93.
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cases that exhibit DHF/DSS. Our results suggest that
virulence markers may be scattered along the dengue
viral genome (Omata et al., 1986). Specifically, the non-
structural gene regions and the 39 noncoding regions. It
has also been previously observed that mutations and
deletions in the 59 NCR could also bring about restriction
of virus growth (Cahour et al., 1995; Kinney et al., 1997).
We speculate that the different combinations of alter-
ations along the whole viral genome could bring about
viruses with enhanced infective capabilities. ThNH-7/93,
isolated from a DSS patient, shows several distinct
genomic differences. The interaction of its characteristic
39 secondary structure with some or all of the sequence
mutations, specifically in the noncoding regions, may
have conferred more virulent properties.
The results from our in vitro experiments show non-
correlation between infectivity and cell-destruction capa-
bility of the virus. The plaque assay also indicates differ-
ences in rates by which the different isolates destroy the
host cells. These differences are probably due to certain
genetic elements of the virus, although they cannot be
ascertained from the nucleic acid sequence data alone.
The data show that the DSS and all DHF isolates (includ-
ing ThNH-p14/93) produced larger plaques than the rest,
though ThNH-p12/93, a DF isolate, also showed signifi-
cantly large plaques. From the plaque assay optimization
experiments, we observed that ThNH-52 and p12/93 con-
sistently produced large, well-formed plaques. ThNH-
p11, p16, and p36/93 showed consistently small and
diffuse plaque morphologies. ThNH-7, 28, p14/93 showed
variable sizes which did not correlate with any of the
factors adjusted during optimization, though plaques
were never smaller than those of isolates from the DF
patients. ThNH-52 and p12/93 are apparently composed
of homogeneously virulent (at least to LLC-MK2 cells)
viruses, while ThNH-7, 28, and p14 are not.
It is interesting to note that all the isolates which
formed large plaques are from patients that had experi-
enced a secondary infection, which emphasizes the im-
portance of host factors in a dengue infection.
Future investigations would include sequencing of iso-
lates from other dengue outbreaks and utilizing an infec-
tious cDNA clone to determine sites or combinations of
sites that may be genetic determinants for virulence.
MATERIALS AND METHODS
Virus isolation
The eight virus isolates used in this study were ob-
tained from the sera of patients from Nakhon Phanom
Provincial Hospital, Northeastern Thailand, diagnosed
with DF, DHF, or DSS during a dengue outbreak in 1993.
Clinical diagnosis confirmation and serotype determina-
tion were performed as described previously (Mangada
and Igarashi, 1997). The clinical diagnosis and clinical
severity grading of each isolate was classified using the
World Health Organization criteria (World Health Organi-
zation, 1986). Relevant patient information is summarized
in Table 1. Medical records show that patient ThNH-
p14/93 was an outpatient and initially expressed symp-
toms of classical dengue fever when serum was ex-
tracted. He was later admitted to the hospital after his
symptoms deteriorated and was classified as DHF grade
I. The isolate from ThNH-p14 is considered a special
DHF case.
Virus sample preparation was performed as described
elsewhere (Mangada and Igarashi, 1997). All isolates were
passaged three times from the patient serum before exper-
imentation: for virus isolation, preparation for large-scale
culture, and the large-scale culture itself. None of the eight
isolates were plaque purified before inoculation into mos-
quito cells. This was done to ensure that the viral speci-
mens were not altered significantly from their wild-type
character as found in the host patient.
Sequencing strategy
Genomic RNA was extracted from purified virus using
a standard guanidinium thiocyanate–phenol–chloroform
method. Nine overlapping cDNA products were prepared
from the purified RNA using SuperScript II, RNase H2
Reverse Transcriptase (GIBCO BRL) as described in the
manufacturer’s instruction manual. The RNA was de-
graded using RNase H and RNase T1 and the cDNA was
purified using water-equilibrated G-50 Sephadex spin
columns. The primer sequences for the cDNA containing
the coding regions were obtained from published se-
quences of the dengue 2 viral genome (Deubel et al.,
1988; Hahn et al., 1988; Irie et al., 1989). The primer
sequences for the 59 noncoding region and the sense
primer sequences for the 39 noncoding region were
obtained from Blok et al. (1992). A poly(dT) primer con-
taining a degenerate 39 terminal nucleotide was used as
the complementary primer for the 39 noncoding region
cDNA. The cDNA nucleotide regions 1–276, 36–1830,
1735–3559, 3405–5193, 4768–6118, 6054–7595, 7164–
9429, 8836–10342, and 10210–10723 were amplified ac-
cording the manufacturer’s instructions by the Expand
High Fidelity PCR System (Boehringer Mannheim) using
a hot-start PCR protocol. The PCR products of regions
1–276 and 10210–10723 were cloned as described pre-
viously (Mangada and Igarashi, 1997). Five clones for
sequencing analysis were chosen from the transfor-
mants and plasmid clones containing the noncoding
regions were extracted from Escherichia coli cells using
the QIAprep Plasmid Miniprep Kit (QIAGEN). The rest of
the PCR products were purified from agarose gels using
the QIAquick PCR Purification Kit (QIAGEN).
Sequencing reactions were performed as recom-
mended in the Taq DyeDeoxy Terminator Sequencing Kit
(Perkin–Elmer/Applied Biosystems Inc.) and the products
were analyzed using an automated Applied Biosystems
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377 or 310 DNA sequencer. Both strands of the cDNA
PCR products were sequenced.
Nucleotide and amino acid sequence analysis
Primer selection, homology searches and compari-
sons of all sequences obtained, and prediction of sec-
ondary structures were done using a DNASIS-Mac ver-
sion 3.6 Software System (Hitachi, 1995). The nucleic
acid secondary structure prediction programs were
based on an algorithm developed by Zuker and Stiegler
(1981) and Salser (1977). The protein analysis software
was based on the Chou and Fasman (1974) criteria for
secondary structure analysis from protein primary struc-
ture. Construction and analysis of the genomic dengue
DNA were done using Sequence Navigator and Factura
software (Perkin–Elmer/Applied Biosystems Inc.).
Phylogenetic analysis
A 240-base sequence spanning the gene junction be-
tween the E structural protein and the NS1 nonstructural
protein was used for comparison among the eight iso-
lates and 40 published sequences of dengue 2 strains.
Dengue 1, 3, and 4 strains were included and one Japa-
nese encephalitis strain was used as an outgroup. This
region was chosen as suggested by the criteria put
forward by Rico-Hesse (1990).
A series of software programs, SeqBoot, DNADIST,
Neighbor, and CONSENSE, that utilize the neighbor-join-
ing method using DNA distance relationships was used
to prepare a dendrogram for the sequences described
previously. This program is a part of the PHYLIP software
distributed by Felsenstein (1989, 1993).
Infectivity assay by focus formation on BHK-21 cells
Infectivity of the isolates was measured by the focus
formation test as modified from the procedure of Okuno
et al. (1985). The overlay medium used after infection of
BHK-21 cells with the isolates was 1.25% methyl cellu-
lose–Eagle’s minimum essential medium containing 2%
fetal calf serum (2% FCS-MEM).
Phenotype assay by plaque formation on LLC-MK2 cells
LLC-MK2 cells were grown in 60-mm plastic petri
dishes (Nunc, Nalgene) to a confluent monolayer. Serial
dilutions of the virus isolates were inoculated onto the
monolayer and adsorbed for 2 h at 37°C with shaking.
The inoculum was then removed and the monolayer was
overlaid with 1% Seaplaque agarose (FMC Bioproducts)
in 1% FCS-MEM, and the plates were incubated at 37°C,
5% CO2, 100% relative humidity for 11 days. To evaluate
plaque size and determine virus titer, the cells were fixed
with 3.7% formaldehyde in PBS for 2 h, the agarose layer
was removed, and the cells were stained with 1.25% w/v
crystal violet for 2 min.
ACKNOWLEDGMENTS
The authors thank Dr. Richard Kinney for his advice about plaque
formation, Dr. Tetsuo Yanagi for his help with the photographs, Dr.
Futoshi Hasebe for his technical advice, and Dr. Ronald Matias for his
counsel and the use of his computer software. The first author is a
recipient of the Monbusho scholarship from the Ministry of Education,
Science, Sports and Culture of the Government of Japan for his stay
and study in the Institute of Tropical Medicine. This study was sup-
ported by the Grant-in-Aid for Scientific Research from the same Min-
istry, Grant No. 07457078 for the fiscal years 1995–1997.
REFERENCES
Barnes, W. S. J., and Rosen, L. (1974). Fatal hemorrhagic disease and
shock associated with primary dengue infection on a Pacific island.
Am. J. Trop. Med. Hyg. 23, 495–506.
Barrett, A. D. T., Monath, T. P., Crop, C. B., Adkins, J. A., Ledger, T. N.,
Gould, E. A., Schlesinger, J. J., Kinney, R. M., and Trent, D. W. (1990).
Attenuation of wild-type yellow fever virus by passage in HeLa cells.
J. Gen. Virol. 71, 2301–2306.
Blok, J., Gibbs, A. J., McWilliam, S. M., and Vitarana, U. T. (1991). NS1
gene sequences from eight dengue 2 viruses and their evolutionary
relationships with other dengue-2 viruses. Arch. Virol. 118, 209–223.
Blok, J., McWilliam, S. M., Butler, H. C., Gibbs, A. J., Weiller, G., Herring,
B. L., Hemsley, A. C., Aaskov, J. G., Yoksan, S., and Bhamarapravati,
N. (1992). Comparison of a dengue-2 virus and its candidate vaccine
derivative: Sequence relationships with the flaviviruses and other
viruses. Virology 187, 573–590.
Cahour, A., Pletnev, A., Vazeille-Falcoz, M., Rosen, L., and Lai, C. J.
(1995). Growth-restricted dengue virus mutants containing deletions
in the 59 noncoding region of the RNA genome. Virology 207, 68–76.
Cecilia, D., and Gould, E. A. (1991). Nucleotide changes responsible for
loss of neuroinvasiveness in Japanese encephalitis virus neutraliza-
tion-resistant mutants. Virology 181, 70–77.
Chaturvedi, U. C., Mukerjee, R., and Dhawan, R. (1994). Active immu-
nization by a dengue virus-induced cytokine. Clin. Exp. Immunol. 96,
202–207.
Chou, P. Y., and Fasman, G. D. (1974). Prediction of protein conforma-
tion. Biochemistry 13, 222–244.
Deubel, V., Kinney, R. M., and Trent, D. W. (1988). Nucleotide sequence
and deduced amino acid sequence of the nonstructural proteins of
dengue type 2 virus, Jamaica genotype: Comparative analysis of the
full-length genome. Virology 165, 234–244.
Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J.,
Stanway, G., Almond, J. W., Currey, K., and Maizel, J. V., Jr. (1985).
Increased neurovirulence associated with a single nucleotide
change in a noncoding region of the Sabin type 3 poliovaccine
genome. Nature 314, p548–550.
Felsenstein, J. (1993). PHYLIP (Phylogeny Inference Package) Version
3.5c. Distributed by the author. Department of Genetics, University of
Washington, Seattle.
Felsenstein, J. (1989). PHYLIP—Phylogeny Inference Package (Version
3.2). Cladistics 5, 164–166.
Fong, M. Y., Koh, C. L., Samuel, S., Pang, T., and Lam, S. K. (1990).
Nucleotide sequences of the nonstructural protein NS1 gene of three
dengue-2 viruses, M1, M2, and M3, isolated in Malaysia from pa-
tients with dengue haemorrhagic fever, dengue shock syndrome and
dengue fever, respectively. Nucleic Acids Res. 18, 1642.
Fu, L., Tan, B. H., Yap, E. H., Chan, Y. C., and Tan, Y. H. (1992). Full length
cDNA sequence of dengue type 1 virus (Singapore strain S275/90).
Virology 188, 953–958.
Gubler, D. J., and Trent, D. W. (1994). Emergence of epidemic dengue/
dengue hemorrhagic fever as a public health problem in the Amer-
icas. Infect. Agent. Dis. 2, 383–393.
Gubler, D. J., Reed, D., Rosen, L., and Hitchcock, J. C., Jr. (1978).
Epidemiologic, clinical and virologic observations on dengue in the
Kingdom of Tonga. Am. J. Trop. Med. Hyg. 27, 581–589.
465COMPARISON OF EIGHT DENGUE 2 ISOLATES
Hahn, C. S., Dalrymple, J. M., Strauss, J. H., and Rice, C. M. (1987).
Comparison of the virulent Asibi strain of yellow fever virus with the
17D vaccine strain derived from it. Proc. Natl. Acad. Sci. USA 84,
2019–2023.
Hahn, Y. S., Galler, R., Hunkapiller, T., Dalrymple, J. M., Strauss, J. H.,
and Strauss, E. G. (1988). Nucleotide sequence of dengue 2 RNA and
comparison of the encoded proteins with those of other flaviviruses.
Virology 162, 167–180.
Halstead, S. B. (1988). Pathogenesis of dengue: Challenges to molec-
ular biology. Science 288, 476–481.
Hasegawa, H., Yoshida, M., Shiosaka, T., Fujita, S., and Kobayashi, Y.
(1992). Mutations in the envelope protein of Japanese encephalitis
virus affect entry into cultured cells and virulence in mice. Virology
191, 158–165.
Holzmann, H., Heinz, F. X., Mandl, C. W., Guirakhoo, F., and Kunz, C.
(1990). A single amino acid substitution in envelope protein E of tick
borne encephalitis virus lead to attenuation in the mouse model.
J. Virol. 64, 5156–5159.
Irie, K., Mohan, P. M., Sasaguri, Y., Putnak, R., and Padmanabhan, R.
(1989). Sequence analysis of cloned dengue virus type 2 genome
(New Guinea-C strain). Gene 75, 197–211.
Jennings, A. D., Gibson, C. A., Miller, B. R., Mathes, J. H., Mitchell, C. J.,
Roehrig, J. T., Wood, D. J., Taffs, F., Sil, B. K., Whitby, S. N., Whitby, J. E.,
Monath, T. P., Minor, P. D., Sanders, P. G., and Barrett, A. D. T. (1994).
Analysis of a yellow fever virus isolated from a fatal case of vaccine
associated human encephalitis. J. Infect. Dis. 169, 512–518.
Jennings, A. D., Whitby, J. E., Minor, P. D., and Barrett, A. D. T. (1993).
Comparison of the nucleotide and deduced amino acid sequences of
the envelope protein genes of the wild-type French viscerotropic
strain of yellow fever virus and the live vaccine strain, French neu-
rotropic vaccine derived from it. Virology 192, 692–695.
Kawano, H., Rostapshov, V., Rosen, L., and Lai, C. J. (1993). Genetic
determinants of dengue type 4 virus neurovirulence for mice. J. Virol.
67, 6567–6575.
Kinney, R. M., Butrapet, S., Chang, G. J. J., Tsuchiya, K. R., Roehrig, J. T.,
Bhamarapravati, N., and Gubler, D. J. (1997). Construction of infec-
tious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated
vaccine derivative, strain PDK-53. Virology 230, 300–308.
Kurane, I., and Ennis, F. A. (1992). Immunity and immunopathology in
dengue virus infections. Semin. Immunol. 4, 121–127.
Kurane, I., and Ennis, F. A. (1994). Cytokines in dengue virus infections:
Role of cytokines in the pathogenesis of dengue hemorrhagic fever.
Semin. Virol. 5, 443–448.
Lai, C. J., Zhao, B., Hiroyuki, H., and Bray, M. (1991). Infectious RNA
transcribed from stably cloned full-length cDNA of dengue type 4
virus. Proc. Natl. Acad. Sci. USA 88, 5139–5143.
Littaua, R., Kurane, I., and Ennis, F. A. (1990). Human IgG Fc receptor II
mediates antibody-dependent enhancement of dengue virus infec-
tion. J. Immunol. 144, 3183–3186.
Lobigs, M., Usha, R., Nestorowicz, A., Marshall, I. D., Weir, R. C., and
Dalgarno, L. (1990). Host cell selection of Murray Valley encephalitis
virus variants altered at an RGD sequence in the envelope protein
and in mouse virulence. Virology 176, 587–595.
Malasit, P. (1987). Complement and dengue haemorrhagic fever/shock
syndrome. South East Asian J. Trop. Med. Public Health 18, 316–320.
Mangada, M. N. M., and Igarashi, A. (1997). Sequences of terminal
noncoding regions from four dengue-2 viruses isolated from patients
exhibiting different disease severities. Virus Genes 14, 5–12.
Men, R., Bray, M., Clark, D., Chanock, R. M., and Lai, C. J. (1996). Dengue
type 4 virus mutants containing deletions in the 39 noncoding region
of the RNA genome: Analysis of growth restriction in cell culture and
altered viremia pattern and immunogenicity in rhesus monkeys.
J. Virol. 70, 3930–3937.
Monath, T. P. (1986). Pathobiology of Flaviviruses. In ‘‘The Togaviridae
and Flaviviridae’’ (S. Schlesinger and M. A. Schlesinger, eds.), pp.
375–440. Plenum, New York.
Monath, T. P., and Heinz, F. X. (1996). Flaviviruses. In ‘‘Fields Virology’’
(B. N. Fields, D. M. Knipe, P. M. Howley et al., Eds.), 3rd ed. pp.
961–1034. Lippincott–Raven, Philadelphia.
Morens, D. M., Marchette, N. J., Chu, M. C., and Halstead, S. B. (1991).
Growth of dengue type 2 virus isolates in human peripheral blood
leukocytes correlates with severe and mild dengue disease. Am. J.
Trop. Med. Hyg. 45, 644–651.
Ni, H., and Barrett, A. D. T. (1996). Molecular differences between
wild-type Japanese encephalitis virus strains of high and low mouse
neuroinvasiveness. J. Gen. Virol. 77, 1449–1455.
Okuno, Y., Fukunaga, T., Tadano, M., Okamoto, Y., Ohnishi, T., and
Takagi, M. (1985). Rapid focus reduction neutralization test of Japa-
nese encephalitis virus in microtiter system. Arch. Virol. 86, 129–135.
Omata, T., Kohara, M., Kuge, S., Komatsu, T., Abe, S., Semler, B. L.,
Kameda, A., Itoh, H., Arita, M., Wimmer, E., and Nomoto, A. (1986).
Genetic analysis of the attenuation phenotype of poliovirus type-1.
J. Virol. 58, 348–358.
Osatomi, K., and Sumiyoshi, H. (1990). Complete nucleotide sequence
of dengue type 3 virus genome RNA. Virology 176, 643–647.
Pletnev, A. G., Bray, M., and Lai, C. J. (1993). Chimeric tick-borne
encephalitis and dengue type 4 viruses: Effects of mutations on
neurovirulence in mice. J. Virol. 67, 4956–4963.
Rice, C. M. (1996). Flaviviruses: The viruses and their replication. In
‘‘Fields Virology’’ (B. N. Fields, D. M. Knipe, P. M. Howley et al., eds.),
3rd ed., pp. 931–959. Lippincott-Raven, Philadelphia.
Rico-Hesse, R. (1990). Molecular evolution and distribution of dengue
viruses type 1 and 2 in nature. Virology 17, 479–493.
Rico-Hesse, R., Harrison, L. M., Salas, R. A., Tovar, D., Nisalak, A.,
Ramos, C., Boshell, J., de Mesa, M. T. R., Nogueira, R. M. R., and da
Rosa, A. T. (1997). Origins of dengue type 2 viruses associated with
increased pathogenicity in the Americas. Virology 230, 244–251.
Rosen, L. (1977). The Emperor’s new clothes revisited, or reflections on
the pathogenesis of dengue hemorrhagic fever: Presidential Ad-
dress. Am. J. Trop. Med. Hyg. 26, 337–343.
Salser, W. (1977). Globin mRNA sequences: Analysis of base pairing
and evolutionary implications. Cold Spring Harbor Symp. Quant. Biol.
42, 985–1002.
Scott, R. M., Nimmannitya, S., Bancroft, W. H., and Mansuwan, P. (1976).
Shock syndrome in primary dengue infections. Am. J. Trop. Med. Hyg.
25, 866–874.
Sumiyoshi, H., Tignor, G. H., and Shope, R. E. (1995). Characterization of
a highly attenuated Japanese encephalitis virus generated from
molecularly cloned cDNA. J. Infect. Dis. 171, 1144–1151.
Thant, K. Z., Morita, K., and Igarashi, A. (1995). Sequences of E/NS1
gene junction from four dengue-2 viruses of northeastern Thailand
and their evolutionary relationship with other dengue-2 viruses. Mi-
crobiol. Immunol. 39, 581–590.
World Health Organization. (1986). ‘‘Dengue Hemorrhagic Fever: Diag-
nosis, Treatment and Control.’’ WHO, Geneva.
Yuill, T. M., Sukhavachan, P., Nisalak, A., and Russell, P. K. (1968).
Dengue virus recovery by direct and delayed plaques in LLC-MK2
cells. Am. J. Trop. Med. Hyg. 14, 441–448.
Zhao, B., Mackow, E., Buckler-White, A., Markoff, L., Chanock, R. M., Lai,
C. J., and Makino, Y. (1986). Cloning full-length dengue type 4 viral
DNA sequences: Analysis of genes coding for structural proteins.
Virology 155, 77–88.
Zuker, M., and Stiegler, P. (1981). Optimal computer folding of large RNA
sequences using thermodynamics and auxiliary information. Nucleic
Acids Res. 9, 133–140.
466 MANGADA AND IGARASHI
